Brief: Helix Biopharma Q1 Loss Per Share C$0.02
13/12/2017 22:35
Dec 13 (Reuters) - Helix Biopharma Corp HBP.TO :
* ANNOUNCES FISCAL FIRST QUARTER 2018 RESULTS
* Q1 LOSS PER SHARE C$0.02
Source text for Eikon: urn:newsml:reuters.com:*:nMKWqqCtta
Further company coverage: HBP.TO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020